梅毒イムノアッセイ診断薬の世界市場

梅毒イムノアッセイ診断薬の世界市場は2030年までに4億4,510万米ドルに達する見込み

2024年に3億5,660万米ドルと推定される梅毒イムノアッセイ診断薬の世界市場は、2024年から2030年にかけてCAGR 3.8%で成長し、2030年には4億4,510万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるアナライザは、CAGR 3.0％を記録し、分析期間終了時には2億6,110万米ドルに達すると予測されます。キット＆試薬セグメントの成長率は、分析期間でCAGR 4.9％と推定されます。

米国市場は9,710万米ドルと推定・中国はCAGR6.8%で成長予測

米国の梅毒イムノアッセイ診断薬市場は、2024年には9,710万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8,900万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と2.9%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界の梅毒イムノアッセイ診断薬市場- 主要動向と促進要因のまとめ

なぜイムノアッセイベースの検査が梅毒診断の中心になりつつあるのか？

梅毒イムノアッセイ診断薬は、その高い特異性、拡張性、活動性感染と潜伏性感染の両方を検出する能力により、性感染症（STI）スクリーニングの要となっています。抗原抗体結合に依存してトレポネーマを検出するこれらの検査法は、ルーチン検査や確認検査として病院、性病診療所、公衆衛生研究所で採用されています。ハイリスク集団やHIVとの同時感染者を含む梅毒の世界の再流行を考えると、その使用の増加は特に重要です。

迅速なポイント・オブ・ケア免疫測定法は、特に資源の限られた地域で、より迅速な治療決定を可能にするため、分散化されたヘルスケア環境で採用されています。自動イムノアッセイ・アナライザーは、集中型ラボの標準となり、他のSTIと並んでハイスループットで多重検査を提供しています。出生前スクリーニングプログラムへの統合により、先天梅毒の予防にも不可欠なものとなっています。早期発見・早期治療が政策的に重視されるようになった現在、免疫測定法は世界の梅毒対策の最前線となっています。

梅毒イムノアッセイ診断の精度と到達度を高めるテクノロジーとは？

イムノアッセイプラットフォームの進化により、分析性能は著しく向上しました。化学発光免疫測定法（CLIA）、酵素結合免疫吸着測定法（ELISA）、および蛍光ベースのシステムは現在、さまざまな病期にわたって優れた感度と特異性を提供しています。トレポネマー抗体と非トレポネマー抗体のデュアル検出形式は、偽陰性を減らし、包括的な血清学的プロファイリングを可能にするために統合されつつあります。

小型化とマイクロフルイディクスにより、ラボのインフラがなくても数分で結果が得られるハンドヘルド機器での迅速なイムノアッセイが可能になりつつあります。単一のカートリッジで梅毒とHIV、肝炎を同時に検査するマルチプレックス免疫測定法が開発されています。さらに、AIを搭載した画像認識ツールは、スキルの低い環境において、より一貫性のあるラテラルフローアッセイを解釈するために使用されています。これらの技術的進歩は、脆弱な人々や移動医療ユニットでのスクリーニングを拡大するために不可欠です。

梅毒検出のためにイムノアッセイの採用が最も急速に増加しているのはどこですか？

成長率の高い市場には、梅毒の有病率が高く、医療システムの近代化が進んでいるサハラ以南のアフリカ、東南アジア、ラテンアメリカが含まれます。公衆衛生イニシアチブは、早期診断を促進し感染を減らすために、地域診療所、移動ユニット、妊産婦保健プログラムで迅速検査キットを積極的に配布しています。

開発途上国では、ハイリスクグループに対する定期的なスクリーニングの推奨が拡大され、性保健クリニック、血液銀行、矯正施設におけるラボベースのイムノアッセイの需要が高まっています。遠隔医療や在宅検査プロバイダーを含む民間セクターも、免疫測定法を直接消費者に提供するSTIキットに組み込んでいます。このような採用チャネルにより、梅毒イムノアッセイ診断薬は世界の保健医療環境に広く普及し、その有用性が高まっています。

梅毒イムノアッセイ診断薬市場の成長はいくつかの要因によって牽引されています。

梅毒イムノアッセイ診断薬市場の成長は、STI症例の世界の増加、イムノアッセイの感度とポータビリティの進歩、早期および大量スクリーニングに対する公衆衛生の義務化の高まりによってもたらされます。臨床検査室における自動化されたハイスループットプラットフォームの統合は、大規模なスクリーニング作業を合理化しています。

迅速なターンアラウンドが可能なポイント・オブ・ケア免疫測定法は、特に妊産婦と新生児の保健プログラムにおいて、遠隔地や十分なサービスを受けていない地域での診断をサポートしています。マルチプレックス・プラットフォームとデジタル化された検査解釈ツールの成長により、検査精度と業務効率が向上しています。さらに、感染症サーベイランスや国際援助プログラムへの投資の増加により、手頃な価格で品質が保証された診断キットへのアクセスが世界的に拡大しています。

セグメント

製品（分析装置、キット＆試薬）;技術（CLIA、ELISA）;エンドユース（血液銀行エンドユース、診断ラボエンドユース、病院エンドユース、その他エンドユース）

調査対象企業の例

• Abbott Laboratories
• AccuQuik（Jal Medical）
• Becton, Dickinson & Company（BD）
• bioMerieux SA
• Bio-Rad Laboratories
• Chembio Diagnostic Systems
• Danaher Corporation（Beckman Coulter）
• DiaSorin S.p.A.
• Fujirebio
• New Industries Biomedical Engineering（SNIBE）
• NOWDiagnostics（NOWDx）
• QuidelOrtho Corporation
• Roche Diagnostics（F. Hoffmann-La Roche）
• Sekisui Chemical Co., Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Siemens Healthineers AG
• Stanbio（Sekisui Specialty Diagnostics）
• Thermo Fisher Scientific, Inc.
• Trinity Biotech

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Syphilis Immunoassay Diagnostics Market to Reach US$445.1 Million by 2030

The global market for Syphilis Immunoassay Diagnostics estimated at US$356.6 Million in the year 2024, is expected to reach US$445.1 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Analyzer, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$261.1 Million by the end of the analysis period. Growth in the Kit & Reagent segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.1 Million While China is Forecast to Grow at 6.8% CAGR

The Syphilis Immunoassay Diagnostics market in the U.S. is estimated at US$97.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$89.0 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Syphilis Immunoassay Diagnostics Market - Key Trends & Drivers Summarized

Why Are Immunoassay-Based Tests Becoming Central to Syphilis Diagnosis?

Syphilis immunoassay diagnostics have become a cornerstone in sexually transmitted infection (STI) screening due to their high specificity, scalability, and ability to detect both active and latent infections. These assays, which rely on antigen-antibody binding to detect Treponema pallidum, are employed across hospitals, sexual health clinics, and public health labs for routine and confirmatory testing. Their growing use is especially significant given the global resurgence of syphilis, including among high-risk populations and co-infected individuals with HIV.

Rapid point-of-care immunoassays are being adopted in decentralized healthcare settings, enabling faster treatment decisions, particularly in resource-limited regions. Automated immunoassay analyzers have become standard in centralized labs, offering high-throughput, multiplex testing alongside other STIs. Their integration into antenatal screening programs has also made them essential in preventing congenital syphilis. With increasing policy emphasis on early detection and treatment, immunoassay diagnostics now form the front line in syphilis control efforts worldwide.

How Is Technology Elevating Syphilis Immunoassay Diagnostic Accuracy and Reach?

The evolution of immunoassay platforms has significantly improved analytical performance. Chemiluminescent immunoassays (CLIA), enzyme-linked immunosorbent assays (ELISA), and fluorescence-based systems now offer superior sensitivity and specificity across different disease stages. Dual treponemal and non-treponemal antibody detection formats are being integrated to reduce false negatives and enable comprehensive serological profiling.

Miniaturization and microfluidics are enabling rapid immunoassays on handheld devices that deliver results within minutes without lab infrastructure. Multiplex immunoassays are being developed to test syphilis alongside HIV and hepatitis in a single cartridge. Additionally, AI-powered image recognition tools are being used to interpret lateral flow assays with greater consistency in low-skill settings. These technological advances are crucial for scaling up screening in vulnerable populations and in mobile healthcare units.

Where Is Immunoassay Adoption Increasing Most Rapidly for Syphilis Detection?

High-growth markets include sub-Saharan Africa, Southeast Asia, and Latin America-regions where syphilis prevalence is high and healthcare systems are undergoing diagnostic modernization. Public health initiatives are actively distributing rapid test kits in community clinics, mobile units, and maternal health programs to facilitate early diagnosis and reduce transmission.

Developed nations are expanding routine screening recommendations for high-risk groups, driving demand for lab-based immunoassays in sexual health clinics, blood banks, and correctional facilities. The private sector, including telehealth and at-home testing providers, is also incorporating immunoassays into direct-to-consumer STI kits. Together, these adoption channels are widening the reach and utility of syphilis immunoassay diagnostics across global health landscapes.

The Growth in the Syphilis Immunoassay Diagnostics Market Is Driven by Several Factors…

It is driven by the global rise in STI cases, advances in immunoassay sensitivity and portability, and increasing public health mandates for early and mass screening. The integration of automated, high-throughput platforms in clinical laboratories is streamlining large-scale screening efforts.

Point-of-care immunoassays with rapid turnaround are supporting diagnostics in remote or underserved regions, particularly within maternal and neonatal health programs. The growth of multiplex platforms and digitized assay interpretation tools is improving test accuracy and operational efficiency. Additionally, increased investment in infectious disease surveillance and international aid programs is expanding access to affordable, quality-assured diagnostic kits worldwide.

SCOPE OF STUDY:

The report analyzes the Syphilis Immunoassay Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Analyzer, Kit & Reagent); Technology (CLIA, ELISA); End-Use (Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AccuQuik (Jal Medical)
• Becton, Dickinson & Company (BD)
• bioMerieux SA
• Bio-Rad Laboratories
• Chembio Diagnostic Systems
• Danaher Corporation (Beckman Coulter)
• DiaSorin S.p.A.
• Fujirebio
• New Industries Biomedical Engineering (SNIBE)
• NOWDiagnostics (NOWDx)
• QuidelOrtho Corporation
• Roche Diagnostics (F. Hoffmann-La Roche)
• Sekisui Chemical Co., Ltd.
• Shenzhen New Industries Biomedical Engineering Co., Ltd.
• Siemens Healthineers AG
• Stanbio (Sekisui Specialty Diagnostics)
• Thermo Fisher Scientific, Inc.
• Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Syphilis Immunoassay Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Syphilis Infections Drives Demand for Accurate Diagnostic Solutions
  • Increased Focus on Early Detection and Screening Programs Expands Use of Immunoassay Tests
  • Advancements in Rapid Point-of-Care Immunoassay Kits Enhance Testing Accessibility
  • Integration of Syphilis Screening Into Routine Antenatal Care Programs Spurs Market Growth
  • Technological Innovation in CLIA and ELISA Platforms Improves Test Sensitivity and Specificity
  • Demand for Multiplex STI Panels Including Syphilis Accelerates Test Consolidation in Labs
  • Growth in Public Health Funding for STI Control Drives Immunoassay Procurement
  • Increased Testing Compliance Mandates in High-Risk Populations Strengthens Diagnostic Uptake
  • Expansion of Sexual Health Clinics and Outreach Programs Fuels Volume-Based Test Adoption
  • Migration Trends and Urbanization Create New Testing Needs in Emerging Economies
  • Rise in Asymptomatic Infections Supports Use of Immunoassays for Population-Wide Surveillance
  • Digital Integration With Laboratory Information Systems Enhances Workflow and Result Management
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Syphilis Immunoassay Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Analyzer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Kit & Reagent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for CLIA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Blood Bank End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Diagnostic Lab End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• JAPAN
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• CHINA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• EUROPE
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• FRANCE
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• GERMANY
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• INDIA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
• AFRICA
  • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION